Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1965 3
1966 3
1967 4
1968 4
1969 3
1970 1
1971 8
1972 12
1973 3
1974 3
1975 5
1976 7
1977 14
1978 5
1979 6
1980 14
1981 12
1982 14
1983 12
1984 12
1985 12
1986 21
1987 16
1988 11
1989 19
1990 18
1991 28
1992 18
1993 18
1994 15
1995 19
1996 26
1997 19
1998 26
1999 34
2000 14
2001 16
2002 16
2003 15
2004 13
2005 5
2006 14
2007 11
2008 9
2009 16
2010 6
2011 7
2012 7
2013 6
2014 2
2015 5
2016 6
2017 4
2018 3
2019 5
2020 5
2021 6
2022 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

627 results

Results by year

Filters applied: . Clear all
Page 1
Inflammation and atherosclerosis.
Libby P, Ridker PM, Maseri A. Libby P, et al. Among authors: maseri a. Circulation. 2002 Mar 5;105(9):1135-43. doi: 10.1161/hc0902.104353. Circulation. 2002. PMID: 11877368 Review.
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators; Van De Werf F, Adgey J, Ardissino D, Armstrong PW, Aylward P, Barbash G, Betriu A, Binbrek AS, Califf R, Diaz R, Fanebust R, Fox K, Granger C, Heikkilä J, Husted S, Jansky P, Langer A, Lupi E, Maseri A, Meyer J, Mlczoch J, Mocceti D, Myburgh D, Oto A, Paolasso E, Pehrsson K, Seabra-Gomes R, Soares-Piegas L, Sùgrue D, Tendera M, Topol E, Toutouzas P, Vahanian A, Verheugt F, Wallentin L, White H. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators, et al. Among authors: maseri a. Lancet. 1999 Aug 28;354(9180):716-22. doi: 10.1016/s0140-6736(99)07403-6. Lancet. 1999. PMID: 10475182 Clinical Trial.
Mixed angina pectoris.
Maseri A, Chierchia S, Kaski JC. Maseri A, et al. Am J Cardiol. 1985 Sep 18;56(9):30E-33E. doi: 10.1016/0002-9149(85)91173-7. Am J Cardiol. 1985. PMID: 3901725 Review.
Viewpoint.
Maseri A. Maseri A. Circulation. 2006 Feb 28;113(8):f29-30. Circulation. 2006. PMID: 16505185 No abstract available.
Mechanisms of myocardial ischemia.
Maseri A. Maseri A. Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 4:827-31. doi: 10.1007/BF00051288. Cardiovasc Drugs Ther. 1990. PMID: 2093377 Review.
Is there a vulnerable plaque?
Maseri A, Fuster V. Maseri A, et al. Circulation. 2003 Apr 29;107(16):2068-71. doi: 10.1161/01.CIR.0000070585.48035.D1. Circulation. 2003. PMID: 12719286 Review. No abstract available.
Inflammation in ischaemic heart disease.
Maseri A, Biasucci LM, Liuzzo G. Maseri A, et al. BMJ. 1996 Apr 27;312(7038):1049-50. doi: 10.1136/bmj.312.7038.1049. BMJ. 1996. PMID: 8616394 Free PMC article. No abstract available.
Coronary Artery Spasm.
Lanza GA, Maseri A. Lanza GA, et al. Among authors: maseri a. Curr Treat Options Cardiovasc Med. 2000 Feb;2(1):83-90. doi: 10.1007/s11936-000-0031-0. Curr Treat Options Cardiovasc Med. 2000. PMID: 11096513
Fibrinogen as a marker of inflammation: a clinical view.
Andreotti F, Burzotta F, Maseri A. Andreotti F, et al. Among authors: maseri a. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S3-4. Blood Coagul Fibrinolysis. 1999. PMID: 10070808 Review. No abstract available.
627 results